ZA931190B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA931190B ZA931190B ZA931190A ZA931190A ZA931190B ZA 931190 B ZA931190 B ZA 931190B ZA 931190 A ZA931190 A ZA 931190A ZA 931190 A ZA931190 A ZA 931190A ZA 931190 B ZA931190 B ZA 931190B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- substituted
- hydrogen
- represents hydrogen
- halogeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203500A GB9203500D0 (en) | 1992-02-19 | 1992-02-19 | Pharmaceutical compositions |
| GB9300921A GB2264299B (en) | 1992-02-19 | 1993-01-19 | Iso-oxazolidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA931190B true ZA931190B (en) | 1994-08-19 |
Family
ID=26300339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA931190A ZA931190B (en) | 1992-02-19 | 1993-02-19 | Pharmaceutical compositions |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5476867A (de) |
| EP (1) | EP0626951B1 (de) |
| JP (1) | JP3464479B2 (de) |
| KR (1) | KR100274479B1 (de) |
| AT (1) | ATE169010T1 (de) |
| AU (1) | AU677176B2 (de) |
| CA (1) | CA2117471C (de) |
| DE (1) | DE69320030T2 (de) |
| DK (1) | DK0626951T3 (de) |
| ES (1) | ES2121075T3 (de) |
| GB (1) | GB2264299B (de) |
| IL (1) | IL104771A (de) |
| NO (1) | NO305027B1 (de) |
| PH (1) | PH31392A (de) |
| WO (1) | WO1993017004A1 (de) |
| ZA (1) | ZA931190B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226857D0 (en) * | 1992-12-23 | 1993-02-17 | Boyd Edward A | Pharmaceutical compositions |
| US7115666B2 (en) * | 2002-10-15 | 2006-10-03 | Renovis, Inc. | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| CA2526209A1 (en) * | 2003-06-12 | 2004-12-23 | Btg International Limited | Cyclic hydroxylamine as psychoactive compounds |
| ITMI20062102A1 (it) * | 2006-11-02 | 2008-05-03 | Abiogen Pharma Spa | Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one |
| ITMI20080768A1 (it) * | 2008-04-24 | 2009-10-25 | Abiogen Pharma Spa | Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one |
| EP2112142A1 (de) * | 2008-04-24 | 2009-10-28 | Abiogen Pharma S.p.A. | Verfahren zur Herstellung eines kristallinen Formverbundstoffs aus 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-on |
| WO2011010332A1 (en) * | 2009-07-23 | 2011-01-27 | Abiogen Pharma S.P.A. | Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1540580A (en) * | 1975-09-02 | 1979-02-14 | Shell Int Research | Fungicidal isoxazolidines |
| US4452799A (en) * | 1981-12-23 | 1984-06-05 | Mead Johnson & Company | Benzisothiazole and benzisoxazole piperazine derivatives |
| US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
| US5114960A (en) * | 1989-07-20 | 1992-05-19 | Hoffmann-La Roche Inc. | Substituted isoxazole derivatives |
| US5114936A (en) * | 1990-08-23 | 1992-05-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use |
-
1993
- 1993-01-19 GB GB9300921A patent/GB2264299B/en not_active Revoked
- 1993-02-17 IL IL10477193A patent/IL104771A/en not_active IP Right Cessation
- 1993-02-17 PH PH45736A patent/PH31392A/en unknown
- 1993-02-18 JP JP51462393A patent/JP3464479B2/ja not_active Expired - Fee Related
- 1993-02-18 CA CA002117471A patent/CA2117471C/en not_active Expired - Lifetime
- 1993-02-18 WO PCT/GB1993/000334 patent/WO1993017004A1/en active IP Right Grant
- 1993-02-18 AT AT93904218T patent/ATE169010T1/de active
- 1993-02-18 DK DK93904218T patent/DK0626951T3/da active
- 1993-02-18 EP EP93904218A patent/EP0626951B1/de not_active Expired - Lifetime
- 1993-02-18 AU AU35086/93A patent/AU677176B2/en not_active Ceased
- 1993-02-18 ES ES93904218T patent/ES2121075T3/es not_active Expired - Lifetime
- 1993-02-18 KR KR1019940702883A patent/KR100274479B1/ko not_active IP Right Cessation
- 1993-02-18 DE DE69320030T patent/DE69320030T2/de not_active Expired - Lifetime
- 1993-02-19 ZA ZA931190A patent/ZA931190B/xx unknown
-
1994
- 1994-08-15 US US08/290,752 patent/US5476867A/en not_active Expired - Lifetime
- 1994-08-17 NO NO943042A patent/NO305027B1/no not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/478,142 patent/US5578626A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO305027B1 (no) | 1999-03-22 |
| ES2121075T3 (es) | 1998-11-16 |
| JPH07504181A (ja) | 1995-05-11 |
| GB9300921D0 (en) | 1993-03-10 |
| KR950700264A (ko) | 1995-01-16 |
| DE69320030T2 (de) | 1998-12-10 |
| JP3464479B2 (ja) | 2003-11-10 |
| EP0626951A1 (de) | 1994-12-07 |
| AU3508693A (en) | 1993-09-13 |
| PH31392A (en) | 1998-10-29 |
| NO943042D0 (no) | 1994-08-17 |
| GB2264299B (en) | 1995-07-26 |
| IL104771A0 (en) | 1994-05-30 |
| ATE169010T1 (de) | 1998-08-15 |
| US5578626A (en) | 1996-11-26 |
| EP0626951B1 (de) | 1998-07-29 |
| CA2117471C (en) | 2003-04-22 |
| IL104771A (en) | 1998-07-15 |
| US5476867A (en) | 1995-12-19 |
| DK0626951T3 (da) | 1999-02-15 |
| AU677176B2 (en) | 1997-04-17 |
| NO943042L (no) | 1994-08-17 |
| DE69320030D1 (de) | 1998-09-03 |
| GB2264299A (en) | 1993-08-25 |
| CA2117471A1 (en) | 1993-09-02 |
| KR100274479B1 (ko) | 2000-12-15 |
| WO1993017004A1 (en) | 1993-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960003604B1 (en) | Benzimidazoline-2-oxo-1-carboxylic acid derivatives | |
| GB9300921D0 (en) | Pharmaceutical compositions | |
| DE59209553D1 (de) | 1,7-anellierte 3-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| KR970009570B1 (en) | Intermediates of aminobenzoic acid | |
| IL108135A0 (en) | Pharmaceutical compositions containing benzoisoxazoles | |
| ATE89818T1 (de) | Dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |